Drugs like semaglutide (marketed as Ozempic and Wegovy) mimic the GLP-1 hormone, enhancing insulin secretion, suppressing appetite, and slowing gastric emptying, thereby promoting weight loss
Some patients may ask about switching from semaglutide to tirzepatide if weight loss slows, side effects become difficult, blood sugar goals change, or they are not seeing the desired response
Adults with a body mass index of 30 or greater, or 27 or greater if they have coexisting conditions, should consider medication along with diet and exercise
Increase Your Dose by 5 Units Per Week To safely increase your dose, aim to increase by 5 units per week as needed
Adults of any weight can qualify if they have confirmed type 2 diabetes and need improved glycemic control
Timing and moderation are more important than cutting out alcohol